Ectiveness and Security of NOACs vs WarfarinYao et alORIGINAL RESEARCHTable 5. Subgroup
Ectiveness and Safety of NOACs vs WarfarinYao et alORIGINAL RESEARCHTable 5. Subgroup Evaluation in Propensity Score atched Rivaroxaban Versus Warfarin UsersRivaroxaban (n=16 175) Event RateWarfarin (n=16 175) Event RateRivaroxaban vs…